Summary & Overview
CPT 52601: Transurethral Resection of Prostate (TURP) Surgical Procedure
CPT code 52601 is a critical billing code for the transurethral resection of the prostate (TURP), a common surgical intervention for patients experiencing urinary symptoms due to benign prostatic hyperplasia. This procedure is widely performed in hospital operating rooms and ambulatory surgical centers, underscoring its importance in urological care across the United States. The code encompasses a complete TURP, including control of postoperative bleeding and several related procedures, making it a comprehensive billing entry for providers.
Major national payers such as Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare recognize and reimburse for CPT code 52601, ensuring broad coverage for patients and providers. This publication offers an in-depth overview of clinical indications, typical sites of service, and related billing codes, as well as policy updates and benchmarks relevant to the code. Readers will gain insight into the clinical context of TURP, associated diagnoses, and how this code fits within the broader landscape of urological procedures. The summary also highlights common modifiers and related CPT codes, providing a complete picture for stakeholders involved in medical billing, policy, and clinical operations.
CPT Code Overview
CPT code 52601 represents a transurethral resection of the prostate (TURP), a urological surgical procedure performed to treat symptoms associated with benign prostatic hyperplasia. This comprehensive procedure includes control of postoperative bleeding, vasectomy, meatotomy, cystourethroscopy, urethral calibration and/or dilation, and internal urethrotomy. The typical site of service for this procedure is the operating room in a hospital or ambulatory surgical center (ASC), reflecting its complexity and the need for specialized surgical facilities.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves a male patient presenting with symptoms of benign prostatic hyperplasia (BPH), such as urinary urgency, hesitancy, incomplete bladder emptying, or lower urinary tract symptoms. The patient has not responded adequately to medical management and is scheduled for a surgical intervention. The procedure, transurethral resection of the prostate (52601), is performed in an operating room at a hospital or ambulatory surgical center by a urologist. The workflow includes preoperative assessment, anesthesia, cystourethroscopy, urethral calibration or dilation, internal urethrotomy if needed, and complete resection of the prostate tissue. Postoperative bleeding is controlled during the procedure, and the patient is monitored for recovery and potential complications.
Coding Specifications
- Modifier
78: Used when there is an unplanned return to the operating/procedure room by the same physician following the initial procedure for a related procedure during the postoperative period.
| Modifier Code | Description |
|---|---|
78 | Unplanned return to the operating/procedure room by the same physician following initial procedure for a related procedure during the postoperative period |
- Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
34 | Urology |
- Specialty Representation:
- Urology: Physicians specializing in the diagnosis and surgical treatment of urinary tract and male reproductive system disorders.
Related Diagnoses
-
N40.1: Benign prostatic hyperplasia with lower urinary tract symptoms- Indicates BPH with symptoms such as urgency, hesitancy, or incomplete bladder emptying, which are common indications for the procedure.
-
N40.0: Benign prostatic hyperplasia without lower urinary tract symptoms- Represents BPH in patients who may not have significant symptoms but require intervention due to other clinical factors.
-
R39.15: Urgency of urination- Symptom often associated with BPH and may contribute to the decision for surgical management.
-
R39.12: Incomplete bladder emptying- Reflects a common symptom of BPH, indicating impaired urinary flow and retention.
-
R39.11: Hesitancy of micturition- Another symptom of BPH, characterized by difficulty initiating urination, supporting the clinical need for intervention.
Related CPT Codes
-
52630: Transurethral resection; residual or regrowth of obstructive prostate tissue including control of postoperative bleeding, complete- Used for repeat procedures when there is regrowth or residual obstructive prostate tissue after the initial resection (
52601). - Commonly used as a follow-up or secondary intervention.
- Used for repeat procedures when there is regrowth or residual obstructive prostate tissue after the initial resection (
-
52648: Laser vaporization of prostate, including control of postoperative bleeding, complete- Represents an alternative surgical technique to
52601, using laser energy instead of resection. - May be selected based on patient factors or provider preference.
- Represents an alternative surgical technique to
These codes are not typically billed together but may be used in sequence (e.g., 52630 after 52601) or as alternatives depending on clinical circumstances.
National Reimbursement Benchmarks
For CPT code 52601, the national mean rate for Medicare is $536.29, which is substantially lower than the BUCA (Blue Cross Blue Shield, UnitedHealth Group, Cigna, and Aetna) average commercial mean rate of $1,006.94. Commercial payers consistently reimburse at higher levels compared to Medicare.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies across payers. Medicare exhibits the tightest range at $35.00, indicating minimal variation in rates. In contrast, UnitedHealth Group shows the widest dispersion at $752.50, reflecting significant variability in commercial reimbursement. Cigna and Blue Cross Blue Shield also display broad ranges, while Aetna and BUCA are moderately dispersed.
The table and chart below present a detailed breakdown of national mean rates and percentile benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.